| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Carlos A Zarate | |
| Nancy DiazGranados | |||
| P2860 | cites work | The prevalence and significance of substance use disorders in bipolar type I and II disorder | Q21203517 |
| Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study | Q28248076 | ||
| Essential role for the PKC target MARCKS in maintaining dendritic spine morphology | Q28568656 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants | Q31036087 | ||
| Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications | Q33540359 | ||
| Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness | Q33782621 | ||
| Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics | Q34622350 | ||
| A systematic review of placebo response in studies of bipolar mania | Q34686878 | ||
| Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen | Q34757926 | ||
| Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement | Q36293331 | ||
| Spines and neurite branches function as geometric attractors that enhance protein kinase C action | Q36321000 | ||
| Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder | Q36400018 | ||
| Adjunctive treatment of acute mania: a clinical overview | Q36905879 | ||
| Weight gain and metabolic issues of medicines used for bipolar disorder | Q37067704 | ||
| Molecular mechanisms of antiestrogen action in breast cancer | Q40644017 | ||
| Protein kinase C and dopamine transport--1. Effects of amphetamine in vivo | Q44442745 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Protein kinase C and dopamine transport--2. Effects of amphetamine in vitro | Q44800543 | ||
| The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
| Stabilization of hypomania following initiation of tamoxifen | Q46616392 | ||
| Clinical trials in bipolar mania: implications in study design and drug development | Q46721063 | ||
| A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder | Q46852634 | ||
| Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. | Q48100054 | ||
| Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. | Q48563872 | ||
| Enhanced protein kinase C activity and translocation in bipolar affective disorder brains | Q48907362 | ||
| Altered platelet protein kinase C activity in bipolar affective disorder, manic episode | Q70765278 | ||
| Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine | Q72258400 | ||
| A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania | Q73347340 | ||
| Cycling into depression from a first episode of mania: a case-comparison study | Q74453207 | ||
| Models of mania and antimanic drug actions: progressing the endophenotype approach | Q81534236 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 510-519 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Current Psychiatry Reports | Q25245507 |
| P1476 | title | A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder | |
| P478 | volume | 10 |
| Q38165755 | Contributions of animal models to the study of mood disorders. |
| Q43923791 | Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania |
| Q53495664 | Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha. |
| Q48056810 | Inositol depletion, GSK3 inhibition and bipolar disorder |
| Q48579986 | Intracerebral Administration of BDNF Protects Rat Brain Against Oxidative Stress Induced by Ouabain in an Animal Model of Mania |
| Q47109377 | Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain |
| Q48331624 | Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania |
| Q34268501 | Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach |
| Q37709574 | New approaches to the pharmacological management of major depressive disorder |
| Q37923845 | New drugs for bipolar disorder |
| Q34026112 | Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients. |
| Q38846159 | Polyphenol compounds and PKC signaling |
| Q30462823 | Predictive animal models of mania: hits, misses and future directions |
| Q37141320 | Protein kinase C, an elusive therapeutic target? |
| Q35785604 | Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior. |
| Q26853509 | Review of pharmacological treatment in mood disorders and future directions for drug development. |
| Q38179926 | Tamoxifen use for the management of mania: a review of current preclinical evidence |
| Q47975522 | The Effects of Histone Deacetylase Inhibition on the Levels of Cerebral Cytokines in an Animal Model of Mania Induced by Dextroamphetamine |
Search more.